Related Experiment Videos
Insights
Diabetic microangiopathy impairs left ventricular function, distinct from metabolic defects. This finding in insulin-requiring diabetics suggests a specific diabetic cardiomyopathy linked to microangiopathy, impacting heart health.
Area of Science:
- Cardiology
- Diabetology
- Nephrology
Background:
- Insulin-requiring diabetes is associated with microvascular complications.
- Diabetic cardiomyopathy is a recognized complication, but its underlying mechanisms require further elucidation.
- Microangiopathy, a common diabetic complication, may play a role in cardiac dysfunction.
Purpose of the Study:
- To investigate left ventricular function in insulin-requiring diabetics with and without significant microangiopathy.
- To compare cardiac function between diabetic subgroups and normal controls.
- To explore the relationship between microangiopathy and impaired left ventricular function.
Main Methods:
- Systolic time intervals were measured to assess left ventricular function.
- Significant microangiopathy was defined by proteinuria (>3 g/24 h) or proliferative retinopathy.
- Echocardiography was used for follow-up assessment in a subset of patients.
- Exclusion criteria included angina, prior myocardial infarction, hypertension, and alcoholism.
Main Results:
- Diabetics with significant microangiopathy demonstrated impaired left ventricular function.
- Patients with uncomplicated diabetes showed normal left ventricular function.
- These findings suggest microangiopathy, not just metabolic defects, contributes to diabetic cardiomyopathy.
Conclusions:
- Microangiopathy is associated with impaired left ventricular function in insulin-requiring diabetics.
- This cardiac dysfunction may represent a specific diabetic cardiomyopathy.
- The link between microangiopathy and impaired heart function could explain increased cardiac mortality post-myocardial infarction in diabetics.
Abstract:
Left ventricular function was assessed by measuring sytolic time intervals in insulin-requiring diabetics with and without significant microangiopathy. The results were compared with those in normal controls. Significant microangiopathy was defined as proteinuria over 3 g/24 h or proliferative retinopathy. Left ventricular function was also assessed one and a half years later by echocardiography in four patients with microangiopathy. Patients with angina, previous myocardial infarction, hypertension, and alcoholism were excluded. All had normal electrocardiograms and chest radiographs. Diabetics with microangiopathy had impaired left ventricular function, whereas those with uncomplicated diabetes had normal function. This finding supports the existence of a specific diabetic cardiomyopathy due to microangiopathy rather than the metabolic defect. The association of microangiopathy and impaired left ventricular function may explain the high immediate mortality and the high incidence of cardiogenic shock and congestive heart failure after myocardial infarction in diabetics.